Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Age Early diagnosis Environmental factors Lifestyle factors Family history 5-year survival decreases significantly with stage of diagnosis2 92% The risk of developing ovarian cancer is increased in women with specific inherited genetic abnormalities. One of these risks is associated with BRCA mutations5 Stage I BRCA1 and BRCA2 belong to a type of genes known as tumour suppressors Up to 39% of women 39% Up to of women who inherit a BRCA1 mutation are likely to develop ovarian cancer 4 Up to 11-17% of women About 1.3% of women Up to 11 - 17% of women who inherit a BRCA2 mutation are likely to develop ovarian cancer 4 with a in the general with a population BRCA2 mutation BRCA1 mut ation Stage II/III OVARIAN CANCER AND GENETIC TESTING Genetic mutations can play a role in the development and treatment of cancer Individuals at risk of carrying a genetic mutation can be referred for genetic testing3 will develop ovarian cancer by age 70 years4 IMPORTANT: As always, please route any materials included in or developed using this document through your internal AstraZeneca review board as well as local regulatory bodies and nominated signatories as appropriate prior to external distribution. References: 1 2 3 4 5 6 Cancer Research UK: Risk Factors for Ovarian Cancer. Available at: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ovary/riskfactors/ Last accessed: May 2016 SEER Cancer Factsheets: Ovary cancer. SEER 18 2003-2009. Available at: http://seer.cancer.gov/statfacts/html/ovary.html Last accessed: May 2016 Gadzicki D, et al. Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet. 2011;2:53-69. National Cancer Institute. BRCA1 and BRCA2: Cancer Risk and Genetic Testing. http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA Last accessed: May 2016 Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609-15. World Cancer Research Fund. Ovarian cancer statistics. Available from: http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/ovarian-cancer-statistics Last accessed; May 2016 Stage IV Date of Expiry: May 2017 of ovarian cancers are diagnosed at the advanced stage 2 Atlas ID: 976,785.011 28% Date of Preparation: May 2016 60% 73% 5-YEAR SURVIVAL Ovarian cancer is the 7 most commonly diagnosed cancer in women worldwide 6 th © 2016 AstraZeneca. All Rights Reserved Several factors may influence the development and prognosis of ovarian cancer, including : 1,2